Addressing the challenges in modern biotherapeutic development

Charter a course to biotherapeutic antibody development success

The rise of bispecific antibodies for use as groundbreaking therapies continues to grow with more than 100 bispecific antibodies currently in development. This is thanks to their remarkable versatility from having dual binding sites targeting two different epitopes, providing advantages such as reducing resistance issues, increased specificity, and identifying unique combinations of drug targets.

However, navigating the intricate challenges of bispecific antibodies is no small feat. That’s why we’ve created this infographic that will aid you on the journey, equipping you with the knowledge to overcome the obstacles along the way and achieve excellence in bispecific antibody development.

Learn more about:

• Stages that make up the bispecific antibody path
• Challenges and considerations faced in development
• Various solutions and technologies available

For research use only. Not for use in diagnostic procedures.